Osage University Partners

Osage University Partners accounts for 33 tracked companies with verified cap-table data, 33 of which disclose round sizes totalling $5.3B. The median disclosed raise is $100M, and the largest is SiFive at $586M, ahead of ReCode Therapeutics ($570M) and Kymeta ($528M).

The names that recur most often on these co-invested cap tables are Osage University Partners (33 companies), OrbiMed (9 companies), Abingworth (5 companies), 5AM Ventures (5 companies), Sanofi Ventures (4 companies), Atlas Venture (3 companies). By latest disclosed round, the market skews Series B (11), Series A (9), Series C (7), Series E (2).

• Companies tracked: 33
• Disclosed funding total: $5.3B across 33 companies
• Median disclosed raise: $100M
• Largest raise: SiFive — $586M
• Stage mix: Series B 11 · Series A 9 · Series C 7 · Series E 2
• Most recent dated round: 2026-05-01

Best funded Osage University Partners companies

1. SiFive — $586M (latest: Series G)
2. ReCode Therapeutics — $570M (latest: Series B)
3. Kymeta — $528M (latest: Series B)
4. Delfi Diagnostics — $400M (latest: Series B)
5. Effector Therapeutics — $325M (latest: Series A)
6. Escient Pharmaceuticals — $238M (latest: Series C)
7. ESCAPE Bio — $184M (latest: Series C)
8. Pairwise Plants — $180M (latest: Series C)
9. MicroTransponder — $173M (latest: Series E)
10. AssetWatch — $153M (latest: Series C)
11. Selecta Biosciences — $151M (latest: Series E)
12. Neuros Medical — $148M (latest: Series D)
13. Overland AI — $142M (latest: Series A)
14. Cyteir Therapeutics — $140M (latest: Series C)
15. Aptinyx — $135M (latest: Series B)

Osage University Partners — related firms and companies (56)

• SiFive
• ReCode Therapeutics
• Kymeta
• Delfi Diagnostics
• Effector Therapeutics
• Escient Pharmaceuticals
• ESCAPE Bio
• Pairwise Plants
• Investors like Felicis
• Investors like Greycroft
• Companies backed by Osage University Partners
• Normunity
• Cyteir Therapeutics
• Investors like Contour Venture Partners
• Investors like Irving Investors
• StreetLight Data
• Precede Biosciences
• Selecta Biosciences
• Investors like Battery Ventures
• Investors like Tiger Global Management
• Dracen Pharmaceuticals
• PMV Pharmaceuticals
• Investors like Notable Capital
• Investors like Storm Ventures
• Investors like HSG
• Q32 Bio
• Nido Biosciences
• Investors like Balderton Capital
• Investors like Mayfield Fund
• Investors like Osage University Partners
• Interius BioTherapeutics
• Overland AI
• Investors like International Finance Corporation
• Investors like Point72 Ventures
• Fortis Therapeutics
• Quantum Circuits
• AssetWatch
• Investors like Zetta Venture Partners
• Investors like Canaan Partners
• Kate Therapeutics
• OncXerna Therapeutics
• Investors like Founder Collective
• Investors like Lux Capital
• Investors like Fika Ventures
• Tessera Labs
• Aptinyx
• Investors like Maven Ventures
• Investors like White Star Capital
• Osage University Partners portfolio companies 2026
• Pionyr Immunotherapeutics
• Neuros Medical
• Investors like Wellington Management
• Investors like Eniac Ventures
• Alphina Therapeutics
• Vanqua Bio
• MicroTransponder

Osage University Partners alternatives · All research reports